Skip to main content
OpenTrials

Clinical trial condition

Synovitis, Pigmented Villonodular

Explore clinical trials studying Synovitis, Pigmented Villonodular. Study availability and eligibility vary by location and protocol.

18 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Synovitis, Pigmented Villonodular trial results

Completed

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

NCT04703322

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
Locations
  • Nagoya University Hospital Aichi, Japan
  • Kyushu University Hospital Fukuoka, Japan
  • Kanazawa University Hospital Ishikawa, Japan
  • National Hospital Organization Osaka National Hospital Osaka, Japan
View Trial Details
Completed

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

NCT01207492

Conditions
Diffuse-type Giant Cell Tumor, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +12 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

NCT05349643

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +12 more
Locations
  • AmMax Bio, Clinical Site Sacramento, California, United States
  • AmMax Bio, Clinical Site Miami, Florida, United States
  • AmMax Bio, Clinical Site Houston, Texas, United States
  • AmMax Bio, Clinical Site Camperdown, Australia
View Trial Details
Completed

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

NCT04731675

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • AmMax Bio Clinical Site Columbus, Ohio, United States
  • AmMax Bio Clinical Site Leiden, Netherlands
  • AmMax Bio Clinical Site Warsaw, Poland
  • AmMax Bio Clinical Site Dnipro, Ukraine
View Trial Details
Completed

Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project

NCT02948088

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +9 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 15 locations
View Trial Details
Completed

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

NCT02371369

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Giant Cell Tumors of the Tendon Sheath, +12 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • UCLA Medical Center Santa Monica, California, United States
View all 39 locations
View Trial Details
Completed

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

NCT02471716

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Sarcoma Oncology Research Center LLC Santa Monica, California, United States
  • Stanford Medicine Stanford, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions